Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Dipanjan Banchur

What Are Wall Street Analysts' Target Price for Kenvue Stock?

Kenvue Inc. (KVUE), headquartered in Skillman, New Jersey, is a consumer health company. Valued at $35.40 billion by market cap, the company is the world’s largest pure-play consumer health company by revenue. Its prominent brands include Aveeno, BAND-AID Brand, Johnson’s, Listerine, Neutrogena, and Tylenol. 

Shares of this leading consumer health company have underperformed the broader market considerably over the past year. KVUE has fallen 24.2% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 20.5%. But in 2024, the gap narrowed, with KVUE stock declining 14.1%, compared to the SPX’s 15.8% gains on a YTD basis.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.